FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Papatheodoridis

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nikolaos Papadopoulos; Dimitrios Tzourmakliotis; Aggeliki Christidou; Melanie Deutsch; Athina Katoglou; Spilios Manolakopoulos; Maria Mela; George V Papatheodoridis
Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.
Aikaterini Margariti; Melanie Deutsch; Spilios Manolakopoulos; Dina Tiniakos; George V Papatheodoridis
The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease.
George V Papatheodoridis
Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Papatheodoridis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nikolaos Papadopoulos; Dimitrios Tzourmakliotis; Aggeliki Christidou; Melanie Deutsch; Athina Katoglou; Spilios Manolakopoulos; Maria Mela; George V Papatheodoridis
Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.
European journal of gastroenterology & hepatology 2013;25(5):587-93.
2013: Aikaterini Margariti; Melanie Deutsch; Spilios Manolakopoulos; Dina Tiniakos; George V Papatheodoridis
The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease.
Journal of clinical gastroenterology 2013;47(3):280-6.
2013: George V Papatheodoridis
Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
Liver international : official journal of the International Association for the Study of the Liver 2013;33 Suppl 1():151-6.
2012: Alexandra Alexopoulou; George V Papatheodoridis
Current progress in the treatment of chronic hepatitis C.
World journal of gastroenterology : WJG 2012;18(42):6060-9.
2012: Spilios Manolakopoulos; A Striki; George V Papatheodoridis
Letter: renal tubular dysfunction during nucleotide analogue therapy in chronic hepatitis B.
Alimentary pharmacology & therapeutics 2012;36(10):992-3; author reply 993.
2012: Ioanna Delladetsima; Angelos Hatzakis; George V Papatheodoridis; Dina G Tiniakos; Nikolaos C Tassopoulos
Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis.
Histopathology 2012;61(5):881-8.
2012: George V Papatheodoridis; Spilios Manolakopoulos; Yun-Fan Liaw; Anna S F Lok
Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review.
Journal of hepatology 2012;57(1):196-202.
2011: Spilios Manolakopoulos; Maria Mela; Melanie Deutsch; Ioannis Ketikoglou; Emanuel K Manesis; Athanasia Striki; Dimitrios Tzourmakliotis; George V Papatheodoridis
Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients.
Liver international : official journal of the International Association for the Study of the Liver 2011;31(10):1525-32.
2011: George V Papatheodoridis; Maria Raptopoulou-Gigi; Giota Touloumi; Irini Vafiadis-Zoumbouli; Themistoklis Vasiliadis; Georgia Vourli; Charalambos Gogos; Ioannis Ketikoglou; Emanuel K Manesis; Spilios Manolakopoulos; Kostas Mimidis
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Gut 2011;60(8):1109-16.
2011: Evangelos Cholongitas; George V Papatheodoridis; Emanuel K Manesis; Kaliopi Petraki; Dina Tiniakos; Stephanos J Hadziyannis
Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.
Journal of medical virology 2011;83(7):1165-71.
2011: Emanuel K Manesis; Theodoros Nastos; Christos Papaioannou; George V Papatheodoridis; Thalia Syminelaki; Dina G Tiniakos; Olga P Agelopoulou; Emilia S Hadziyannis; Peter Karayiannis
Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Journal of hepatology 2011;55(1):61-8.
2011: Emmanuel A Tsochatzis; George V Papatheodoridis
Is there any progress in the treatment of non-alcoholic fatty liver disease?
World journal of gastrointestinal pharmacology and therapeutics 2011;2(1):1-5.
2011: Ioannis P Giannousis; Emilia S Hadziyannis; Spilios G Manolakopoulos; Anastasia Georgiou; George V Papatheodoridis
Changes of serum levels of keratin-18 fragments in hepatitis B e antigen-negative chronic hepatitis B patients under oral antiviral therapy.
Antiviral therapy 2011;16(4):505-14.
2011: Maria-Vasiliki Papageorgiou; George V Papatheodoridis; Spilios Manolakopoulos; Emmanuel Tsochatzis; Hariklia Kranidioti; Georgia Kafiri; Athanasios I Archimandritis
Elastography for hepatic fibrosis severity in chronic hepatitis B or C.
Case reports in gastroenterology 2011;5(1):63-72.
2011: Yun-Fan Liaw; I-Shyan Sheen; Chuan-Mo Lee; Ulus Salih Akarca; George V Papatheodoridis; Florence Suet-Hing Wong; Ting-Tsung Chang; Andrzej Horban; Chia Wang; Peter Kwan; Maria Buti; Martin Prieto; Thomas Berg; Kathryn Kitrinos; Ken Peschell; Elsa Mondou; David Frederick; Franck Rousseau; Eugene R Schiff
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.
Hepatology (Baltimore, Md.) 2011;53(1):62-72.
2011: George V Papatheodoridis
Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues.
Liver international : official journal of the International Association for the Study of the Liver 2011;31 Suppl 1():95-103.
2010: Spilios Manolakopoulos; Melanie J Deutsch; Olga Anagnostou; Stelios Karatapanis; Elli Tiniakou; George V Papatheodoridis; Ekaterini Georgiou; Emanuel K Manesis; Dimitrios Tzourmakliotis; Athanasios J Archimandritis
Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
Liver international : official journal of the International Association for the Study of the Liver 2010;30(10):1454-60.
2010: Emmanuel Tsochatzis; George V Papatheodoridis; Vasiliki Koliaraki; Emilia S Hadziyannis; G Kafiri; Emanuel K Manesis; A Mamalaki; Athanasios Archimandritis
Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
Journal of viral hepatitis 2010;17(11):800-6.
2010: Emmanuel A Tsochatzis; George V Papatheodoridis
Smoking is associated with histological severity in nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2010;52(4):1522-3.
2010: Melanie Deutsch; George V Papatheodoridis
Danoprevir, a small-molecule NS3/4A protease inhibitor for the potential oral treatment of HCV infection.
Current opinion in investigational drugs (London, England : 2000) 2010;11(8):951-63.
2010: George V Papatheodoridis; Pietro Lampertico; Spilios Manolakopoulos; Anna S F Lok
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.
Journal of hepatology 2010;53(2):348-56.
2010: Effrosini G Panayotopoulou; Dionyssios Nicholas Sgouras; Konstantinos S Papadakos; Kalliopi Petraki; Sébastien Breurec; Spyros Michopoulos; Gerassimos Mantzaris; George V Papatheodoridis; Andreas Mentis; Athanasios Archimandritis
CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease.
Journal of clinical microbiology 2010;48(6):2237-9.
2010: George V Papatheodoridis; Emilia Hadziyannis; Emmanuel Tsochatzis; Anastasia Georgiou; Georgia Kafiri; Dina G Tiniakos; Katerina Margariti; Spilios Manolakopoulos; Emanuel K Manesis; Athanasios J Archimandritis
Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.
Journal of clinical gastroenterology 2010;44(4):e87-95.
2010: George V Papatheodoridis; John Vlachogiannakos; Ioannis Karaitianos; Demetrios G Karamanolis
A Greek survey of community prevalence and characteristics of constipation.
European journal of gastroenterology & hepatology 2010;22(3):354-60.
2010: Evangelos Cholongitas; George V Papatheodoridis; Andrew Kenneth Burroughs
Liver grafts from anti-hepatitis B core positive donors: a systematic review.
Journal of hepatology 2010;52(2):272-9.
2010: Dina G Tiniakos; George V Papatheodoridis
Serum markers of hepatocyte apoptosis: current terminology and predictability in clinical practice.
Hepatology (Baltimore, Md.) 2010;51(2):717-8.
2010: Ioannis P Giannousis; George V Papatheodoridis; Melanie J Deutsch; Spilios G Manolakopoulos; Emanuel K Manesis; John Koskinas; Athanasios J Archimandritis
The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
European journal of gastroenterology & hepatology 2010;22(2):172-9.
2009: George V Papatheodoridis; Nikolaos V Chrysanthos; Evangelos Cholongitas; Efthymia Pavlou; George Apergis; Dina G Tiniakos; Evangelia Andrioti; George Theodossiades; Athanasios J Archimandritis
Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
Journal of hepatology 2009;51(5):931-8.
2009: Emmanuel Tsochatzis; Spilios Manolakopoulos; George V Papatheodoridis; Emilia S Hadziyannis; Christos Triantos; K Zisimopoulos; I Goulis; Dimitrios Tzourmakliotis; E Akriviadis; Emanuel K Manesis; Athanasios Archimandritis
Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
Alimentary pharmacology & therapeutics 2009;30(9):947-54.
2009: George V Papatheodoridis; Evangelos Cholongitas; Athanasios J Archimandritis; Andrew Kenneth Burroughs
Current management of hepatitis B virus infection before and after liver transplantation.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(9):1294-305.
2009: Spilios Manolakopoulos; Christos Triantos; Jiannis Theodoropoulos; Jiannis Vlachogiannakos; Anastasios Kougioumtzan; George V Papatheodoridis; Dimitrios Tzourmakliotis; Dimitrios G Karamanolis; Andrew Kenneth Burroughs; Athanasios Archimandritis; Sotirios Raptis; Alec Avgerinos
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
Journal of hepatology 2009;51(3):468-74.
2009: F Ntziora; Dimitrios Paraskevis; Catherine Haida; Emmanouil Magiorkinis; E Manesis; George V Papatheodoridis; Spilios Manolakopoulos; Apostolos Beloukas; S Chryssoy; Gkikas Magiorkinis; Vana Sypsa; Angelos Hatzakis
Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology.
Journal of clinical microbiology 2009;47(8):2544-50.
2009: George V Papatheodoridis; Spilios Manolakopoulos
EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy.
Journal of hepatology 2009;51(1):226-7.
2009: A Mavrogiannaki; Basil G Karamanos; Emanuel K Manesis; George V Papatheodoridis; John Koskinas; Athanasios Archimandritis
Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
Journal of viral hepatitis 2009;16(6):430-6.
2009: Emmanuel A Tsochatzis; George V Papatheodoridis; Athanasios J Archimandritis
Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy.
Mediators of inflammation 2009;2009():831670.
2009: Emmanuel Tsochatzis; George V Papatheodoridis; Spilios Manolakopoulos; Dina G Tiniakos; Emanuel K Manesis; Athanasios J Archimandritis
Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.
Scandinavian journal of gastroenterology 2009;44(6):752-9.
2008: George V Papatheodoridis; Spilios Manolakopoulos; Athanasios J Archimandritis
Current treatment indications and strategies in chronic hepatitis B virus infection.
World journal of gastroenterology : WJG 2008;14(45):6902-10.
2008: George V Papatheodoridis; Emanuel K Manesis; Spilios Manolakopoulos; Ioannis S Elefsiniotis; John Goulis; John Giannousis; Antonios Bilalis; Georgia Kafiri; Dimitrios Tzourmakliotis; Athanasios J Archimandritis
Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
Hepatology (Baltimore, Md.) 2008;48(5):1451-9.
2008: George V Papatheodoridis; Melanie Deutsch
Resistance issues in treating chronic hepatitis B.
Future microbiology 2008;3(5):525-38.
2008: Nicolaos C Tassopoulos; George V Papatheodoridis; Ioanna Delladetsima; Angelos Hatzakis
Clinicopathological features and natural history of acute sporadic non-(A-E) hepatitis.
Journal of gastroenterology and hepatology 2008;23(8 Pt 1):1208-15.
2008: George V Papatheodoridis; Dimitrios Paraskevis
Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(6):764-6.
2008: George V Papatheodoridis; N Chrysanthos; Emilia S Hadziyannis; Evangelos Cholongitas; Emanuel K Manesis
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
Journal of viral hepatitis 2008;15(6):434-41.
2008: George V Papatheodoridis; Emilia S Hadziyannis; Emmanuel Tsochatzis; Nikolaos V Chrysanthos; A Georgiou; Georgia Kafiri; Spilios Manolakopoulos; Dina G Tiniakos; I Giannousis; Emanuel K Manesis; Athanasios Archimandritis
Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
Gut 2008;57(4):500-6.
2008: Nikolaos Sevastos; Emanuel K Manesis; Savvas P Savvas; Nikolaos Galiatsatos; George V Papatheodoridis; Athanasios J Archimandritis
Changes of liver and muscle enzymes activity in patients with rigor.
European journal of internal medicine 2008;19(2):109-14.
2008: George V Papatheodoridis; Spilios Manolakopoulos; Geoffrey Dusheiko; Athanasios J Archimandritis
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.
The Lancet infectious diseases 2008;8(3):167-78.
2008: Evangelos Cholongitas; Vibhakorn Shusang; George V Papatheodoridis; Laura Marelli; Pinelopi Manousou; Nancy Rolando; David Patch; Keith Rolles; Brian Davidson; Andrew Kenneth Burroughs
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(2):138-43.
2008: Aristotelis Bamias; Vassiliki Koutsoukou; Evangelos Terpos; Marinos L Tsiatas; Christina Liakos; Ourania E Tsitsilonis; Alexandros Rodolakis; Zannis Voulgaris; George Vlahos; Theoharis Papageorgiou; George V Papatheodoridis; Athanasios Archimandritis; Aris Antsaklis; Meletios A Dimopoulos
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Gynecologic oncology 2008;108(2):421-7.
2008: Spilios Manolakopoulos; Sotirios Bethanis; S Koutsounas; John Goulis; Jiannis Vlachogiannakos; E Christias; Adamos Saveriadis; C Pavlidis; Christos Triantos; A Christidou; George V Papatheodoridis; Dimitrios G Karamanolis; Dimitrios Tzourmakliotis
Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
Alimentary pharmacology & therapeutics 2008;27(3):266-73.
2008: Maria Tzouvala; Andreas C Lazaris; George V Papatheodoridis; Chariklia Kouvidou; Thomas Papathomas; Nikos Kavantzas; Ioannis Elemenoglou; Dimitrios G Karamanolis; Emmanouil Agapitos
Potential role of apoptosis and apoptotic regulatory proteins in colorectal neoplasia: correlations with clinico-pathological parameters and survival.
Digestive diseases and sciences 2008;53(2):451-60.
2008: Emmanuel Tsochatzis; George V Papatheodoridis; Emilia S Hadziyannis; Anastasia Georgiou; Georgia Kafiri; Dina G Tiniakos; Emanuel K Manesis; Athanasios J Archimandritis
Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Scandinavian journal of gastroenterology 2008;43(9):1128-36.
2008: George V Papatheodoridis
Ethics related to liver biopsies and antiviral therapies in chronic viral hepatitis.
Digestive diseases (Basel, Switzerland) 2008;26(1):59-65.
2008: Melanie Deutsch; George V Papatheodoridis; Anastasia Tzakou; Stephanos J Hadziyannis
Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
European journal of gastroenterology & hepatology 2008;20(1):5-9.
2008: Emmanuel Tsochatzis; George V Papatheodoridis; Emanuel K Manesis; Georgia Kafiri; Dina G Tiniakos; Athanasios J Archimandritis
Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Alimentary pharmacology & therapeutics 2008;27(1):80-9.
2007: Emmanuel Tsochatzis; George V Papatheodoridis; Athanasios J Archimandritis
Adipokines and insulin resistance in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2007;46(6):2050-1; author reply 2051.
2007: Emmanuel Tsochatzis; George V Papatheodoridis; Emanuel K Manesis; Nikolaos V Chrysanthos; Georgia Kafiri; Athanasios J Archimandritis
Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2007;39(10):936-42.
2007: George V Papatheodoridis; Emanuel K Manesis; Spilios Manolakopoulos; Athanasios J Archimandritis
Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection.
Hepatology (Baltimore, Md.) 2007;46(2):606-7; author reply 607.
2007: Aristotelis Bamias; Marinos L Tsiatas; E Kafantari; C Liakou; Alexandros Rodolakis; Zannis Voulgaris; George Vlahos; Theoharis Papageorgiou; Ourania E Tsitsilonis; Christina Bamia; George V Papatheodoridis; Ek Politi; Athanasios Archimandritis; Aris Antsaklis; Meletios A Dimopoulos
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Gynecologic oncology 2007;106(1):75-81.
2007: Dimitrios G Karamanolis; Ioannis Kyrlagkitsis; K Konstantinou; George V Papatheodoridis; Andreas Karameris; Elias Mallas; Spiros D Ladas; S Raptis
The Bcl-2/Bax system and apoptosis in ulcerative colitis.
Hepato-gastroenterology 2007;54(76):1085-8.
2007: Emmanuel Tsochatzis; Dimitrios Vassilopoulos; Emanuel K Manesis; George V Papatheodoridis; Ageliki Bousiotou; Emilia S Hadziyannis; Athanasios J Archimandritis
First appearance of Crohn's disease following infliximab treatment for spondylarthropathy.
Scandinavian journal of gastroenterology 2007;42(6):784-5.
2007: Emmanuel Tsochatzis; George V Papatheodoridis; Ioannis S Elefsiniotis; S Thanelas; George Theodossiades; Antonios Moulakakis; Athanasios J Archimandritis
Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2007;39(5):490-4.
2007: Evangelos Cholongitas; George V Papatheodoridis; Paola Zappoli; Athanasios Giannakopoulos; David Patch; Laura Marelli; Vibhakorn Shusang; George Kalambokis; Graham Shirling; Nancy Rolando; Andrew Kenneth Burroughs
Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(4):552-7.
2007: George V Papatheodoridis; John Goulis; Dimitrios Christodoulou; Spilios Manolakopoulos; Maria Raptopoulou; Evangelia Andrioti; Nikolaos Alexandropoulos; Savoula Savvidou; Aikaterini Papachristou; Eleftheria K Zervou; Konstantin Seferiadis; Polyxeni Kousidou; Evangelos Vogiatzakis; Epameinondas Tsianos
High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
European journal of gastroenterology & hepatology 2007;19(4):281-7.
2007: Emmanuel Tsochatzis; George V Papatheodoridis; Emanuel K Manesis; Nikolaos V Chrysanthos; Georgia Kafiri; Kalliopi Petraki; Emilia S Hadziyannis; Helen Pandelidaki; Rodessa Zafiropoulou; Savvas P Savvas; John Koskinas; Athanasios J Archimandritis
Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
The American journal of gastroenterology 2007;102(3):634-41.
2007: Effrosini G Panayotopoulou; Dionyssios Nicholas Sgouras; Konstantinos Papadakos; Antonios Kalliaropoulos; George V Papatheodoridis; Andreas Mentis; Athanasios J Archimandritis
Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates.
Journal of clinical microbiology 2007;45(2):488-95.
2007: Emanuel K Manesis; Maria Schina; Frédéric Le Gal; Olga Agelopoulou; Christos Papaioannou; Constantine Kalligeros; Vaios Arseniou; Spilios Manolakopoulos; Emilia S Hadziyannis; Elyanne Gault; John Koskinas; George V Papatheodoridis; Athanasios J Archimandritis
Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
Antiviral therapy 2007;12(3):381-8.
2007: Maria Schina; George V Papatheodoridis; Antonios G Antoniadis; Emmanouil Magiorkinis; Dimitrios Paraskevis; Panagiotis Tsavtaridis; Nikos Sakellaropoulos; Angelos Hatzakis
HBsAg-negative HBV mutant transfusion-related acute hepatitis B.
The American journal of gastroenterology 2007;102(1):216-7.
2007: Antigoni Katsoulidou; Z Moschidis; Vana Sypsa; M Chini; George V Papatheodoridis; Nicolaos C Tassopoulos; Konstantinos Mimidis; Anastasia Karafoulidou; Angelos Hatzakis
Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Vox sanguinis 2007;92(1):8-14.
2006: Emmanuel Tsochatzis; George V Papatheodoridis; Athanasios J Archimandritis
The evolving role of leptin and adiponectin in chronic liver diseases.
The American journal of gastroenterology 2006;101(11):2629-40.
2006: Christos Triantos; John Goulis; David Patch; George V Papatheodoridis; Gioacchino Leandro; Dimitrios Samonakis; Evangelos Cholongitas; Andrew Kenneth Burroughs
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye.
Endoscopy 2006;38(8):797-807.
2006: George V Papatheodoridis; Spilios Manolakopoulos
Drug evaluation: LB-80380--a novel phosphonate nucleoside for the potential treatment of HBV infection.
Current opinion in molecular therapeutics 2006;8(4):352-7.
2006: Emmanuel Tsochatzis; Marino Venerito; George V Papatheodoridis; Athanasios J Archimandritis; Klaus Mönkemüller; Peter Malfertheiner; Steffen Rickes
Hepatobiliary and pancreatic: spontaneous splenorenal shunts in portal hypertension.
Journal of gastroenterology and hepatology 2006;21(7):1214.
2006: Stephanos J Hadziyannis; George V Papatheodoridis
Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.
Seminars in liver disease 2006;26(2):130-41.
2006: George V Papatheodoridis; Nikolaos V Chrysanthos; Savvas P Savvas; Vasilios Sevastianos; Georgia Kafiri; Kalliopi Petraki; Emanuel K Manesis
Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Journal of viral hepatitis 2006;13(5):303-10.
2006: Melanie Deutsch; Kiriakos Vasiliou; George V Papatheodoridis
Hepatocellular carcinoma presenting with pleuritic pain.
European journal of internal medicine 2006;17(3):222.
2006: Nikolaos V Chrysanthos; George V Papatheodoridis; Savvas P Savvas; Georgia Kafiri; Kalliopi Petraki; Emanuel K Manesis; Athanasios J Archimandritis
Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis.
European journal of gastroenterology & hepatology 2006;18(4):389-96.
2006: Evangelos Cholongitas; George V Papatheodoridis; Emanuel K Manesis; Andrew Kenneth Burroughs; Athanasios J Archimandritis
Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial?
Journal of gastroenterology and hepatology 2006;21(3):581-7.
2006: Nikolaos Sevastos; George Theodossiades; Stamatis Efstathiou; George V Papatheodoridis; Emanuel K Manesis; Athanasios J Archimandritis
Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude.
The Journal of laboratory and clinical medicine 2006;147(3):139-44.
2006: George V Papatheodoridis; Stavros Sougioultzis; Athanasios J Archimandritis
Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(2):130-42.
2006: Konstantinos Koutroutsos; Dimitrios Tsiachris; George V Papatheodoridis; Dina G Tiniakos; Rodessa Zafiropoulou; Athanasios J Archimandritis
Simultaneous diagnosis of ulcerative jejunoileitis and coeliac disease in an elderly man.
Digestion 2006;73(1):20-4.
2006: Emanuel K Manesis; George V Papatheodoridis; Stephanos J Hadziyannis
A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B.
Alimentary pharmacology & therapeutics 2006;23(1):99-106.
2005: Evangelos Cholongitas; George V Papatheodoridis; Marcello Vangeli; Natalia Terreni; David Patch; Andrew Kenneth Burroughs
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?
Alimentary pharmacology & therapeutics 2005;22(11-12):1079-89.
2005: Vana Sypsa; Giota Touloumi; George V Papatheodoridis; Nicolaos C Tassopoulos; Ioannis Ketikoglou; Irene Vafiadis; Grigorios S Hatzis; Dimitrios Tsantoulas; E Akriviadis; S Koutsounas; Angelos Hatzakis
Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments.
Journal of viral hepatitis 2005;12(5):543-50.
2005: George V Papatheodoridis; Athanasios J Archimandritis
Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.
World journal of gastroenterology : WJG 2005;11(25):3811-6.
2005: George V Papatheodoridis; Evangelini Dimou; Konstantinos Dimakopoulos; Spilios Manolakopoulos; Irene Rapti; George Kitis; Dimitrios Tzourmakliotis; Emanuel K Manesis; Stephanos J Hadziyannis
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.
Hepatology (Baltimore, Md.) 2005;42(1):121-9.
2005: George V Papatheodoridis; Evangelos Cholongitas; Eleni Dimitriadou; Giota Touloumi; Vassilios Sevastianos; Athanasios J Archimandritis
MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis.
World journal of gastroenterology : WJG 2005;11(20):3099-104.
2005: George V Papatheodoridis; Dimitrios G Karamanolis
Prevalence and impact of upper and lower gastrointestinal symptoms in the Greek urban general population.
Scandinavian journal of gastroenterology 2005;40(4):412-21.
2005: Dimitrios Samonakis; Christos Triantos; Ulrich Thalheimer; Alberto Quaglia; Gioacchino Leandro; Rosângela Teixeira; George V Papatheodoridis; Caroline A Sabin; Nancy Rolando; Susan Davies; Amar P Dhillon; Paul Griffiths; Vincent Emery; David Patch; Brian R Davidson; Keith Rolles; Andrew Kenneth Burroughs
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(4):386-95.
2005: George V Papatheodoridis; Kalliopi Petraki; Evangelos Cholongitas; E Kanta; Ioannis Ketikoglou; Emanuel K Manesis
Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B.
Journal of viral hepatitis 2005;12(2):199-206.
2005: Evangelos Cholongitas; George V Papatheodoridis; Alexandros Lahanas; ANNA XANTHAKI; Chrysoula Kontou-Kastellanou; Athanasios J Archimandritis
Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(1):57-61.
2004: Stephanos J Hadziyannis; George V Papatheodoridis
Emerging treatments in chronic hepatitis B.
Expert opinion on emerging drugs 2004;9(2):207-21.
2004: Evangelos Cholongitas; Anastasia Mavrogiannaki; Christos Papaioannou; Stefanos Karagiannis; George V Papatheodoridis
Pericarditis and possible antiphospholipid syndrome on primary biliary cirrhosis.
Annals of hepatology 2004;3(4):167-8.
2004: Stephanos J Hadziyannis; George V Papatheodoridis
Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.
Expert review of anti-infective therapy 2004;2(4):475-83.
2004: George V Papatheodoridis; Evangelos Cholongitas
Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options.
Journal of viral hepatitis 2004;11(4):287-96.
2004: George V Papatheodoridis; Despina Papadelli; Evangelos Cholongitas; Dimitrios Vassilopoulos; Andreas Mentis; Stephanos J Hadziyannis
Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
The American journal of medicine 2004;116(9):601-5.
2004: George V Papatheodoridis; Stephanos J Hadziyannis
Review article: current management of chronic hepatitis B.
Alimentary pharmacology & therapeutics 2004;19(1):25-37.
2003: Chun-Wing Chan; George V Papatheodoridis; John Goulis; Andrew Kenneth Burroughs
Ursodeoxycholic acid and histological progression in primary biliary cirrhosis.
Journal of hepatology 2003;39(6):1094-5.
2003: Stephanos J Hadziyannis; George V Papatheodoridis; Dimitrios Vassilopoulos
Precore mutant chronic hepatitis B - approach to management.
MedGenMed : Medscape general medicine 2003;5(4):1.
2003: Emanuel K Manesis; George V Papatheodoridis; Vasilios Sevastianos; Evangelos Cholongitas; Christos Papaioannou; Stephanos J Hadziyannis
Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
The American journal of gastroenterology 2003;98(10):2261-7.
2003: Evangelos Cholongitas; George V Papatheodoridis; Anastasia Mavrogiannaki; Emanuel K Manesis
Naftidrofuryl-induced liver injury.
The American journal of gastroenterology 2003;98(6):1448-50.
2003: Stephanos J Hadziyannis; George V Papatheodoridis
Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.
Expert opinion on pharmacotherapy 2003;4(4):541-51.
2003: George V Papatheodoridis; Vasilios Sevastianos; Andrew Kenneth Burroughs
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(3):250-8.
2003: George V Papatheodoridis; E Papakonstantinou; E Andrioti; Evangelos Cholongitas; Kalliopi Petraki; I Kontopoulou; S J Hadziyannis
Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.
Gut 2003;52(3):404-9.
2003: Stephanos J Hadziyannis; George V Papatheodoridis; Dimitrios Vassilopoulos
Treatment of HBeAg-negative chronic hepatitis B.
Seminars in liver disease 2003;23(1):81-8.
2003: Maria Luisa Raimondo; Lucy Dagher; George V Papatheodoridis; Nancy Rolando; David Patch; Brian R Davidson; Keith Rolles; Andrew Kenneth Burroughs
Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
Transplantation 2003;75(2):186-90.
2003: Stephanos J Hadziyannis; George V Papatheodoridis
Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others).
Journal of hepatology 2003;39 Suppl 1():S172-6.
2002: Stephanos S Karagiannis; George V Papatheodoridis; Evangelos Cholongitas; Emanuel K Manesis
Mesenteric venous thrombosis after transcatheter arterial chemoembolization for hepatocellular carcinoma.
The American journal of gastroenterology 2002;97(10):2685-6.
2002: George V Papatheodoridis; Emilia S Hadziyannis; Melanie Deutsch; Stephanos J Hadziyannis
Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial.
The American journal of gastroenterology 2002;97(8):2063-70.
2002: Nikolaos Sevastos; Petros I Rafailidis; Kyriakos Kolokotronis; Konstantina Papadimitriou; George V Papatheodoridis
Primary aortojejunal fistula due to foreign body: a rare cause of gastrointestinal bleeding.
European journal of gastroenterology & hepatology 2002;14(7):797-800.
2002: George V Papatheodoridis; Evangelini Dimou; Vassilios Papadimitropoulos
Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
The American journal of gastroenterology 2002;97(7):1618-28.
2002: George V Papatheodoridis; Evangelini Dimou; Andreas Laras; Vassilios Papadimitropoulos; Stephanos J Hadziyannis
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease.
Hepatology (Baltimore, Md.) 2002;36(1):219-26.
2002: Emanuel K Manesis; George V Papatheodoridis; Stephanos J Hadziyannis
Serum HBV-DNA levels in inactive hepatitis B virus carriers.
Gastroenterology 2002;122(7):2092-3; author reply 2093.
2001: Nikolaos Sevastos; K Kolokotronis; George V Papatheodoridis
Acute pancreatitis associated with Salmonella enteritidis.
The American journal of gastroenterology 2001;96(12):3450-1.
2001: George V Papatheodoridis; Stephanos J Hadziyannis
Diagnosis and management of pre-core mutant chronic hepatitis B.
Journal of viral hepatitis 2001;8(5):311-21.
2001: George V Papatheodoridis; S Davies; Amar P Dhillon; Rosângela Teixeira; John Goulis; Brian Davidson; Keith Rolles; Geoffrey Dusheiko; Andrew Kenneth Burroughs
The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis.
Transplantation 2001;72(3):412-8.
2001: R Teixeira; George V Papatheodoridis; Andrew Kenneth Burroughs
Management of recurrent hepatitis C after liver transplantation.
Journal of viral hepatitis 2001;8(3):159-68.
2001: George V Papatheodoridis; Vassilios Papadimitropoulos; Stephanos J Hadziyannis
Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.
Alimentary pharmacology & therapeutics 2001;15(5):689-98.
2001: George V Papatheodoridis; Emanuel K Manesis; Stephanos J Hadziyannis
The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B.
Journal of hepatology 2001;34(2):306-13.
2000: Stephanos J Hadziyannis; George V Papatheodoridis; Evangelini Dimou; Andreas Laras; Christos Papaioannou
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.
Hepatology (Baltimore, Md.) 2000;32(4 Pt 1):847-51.
1999: George V Papatheodoridis; S Chung; Satish Keshav; J Pasi; Andrew Kenneth Burroughs
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis.
Journal of hepatology 1999;31(4):747-50.
1999: George V Papatheodoridis; John Goulis; Gioacchino Leandro; David Patch; Andrew Kenneth Burroughs
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.
Hepatology (Baltimore, Md.) 1999;30(3):612-22.
1999: George V Papatheodoridis; S G Barton; D Andrew; GS Clewley; S Davies; Amar P Dhillon; Geoffrey Dusheiko; B Davidson; Keith Rolles; Andrew Kenneth Burroughs
Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens.
Gut 1999;45(3):427-34.
1999: Stephanos J Hadziyannis; George V Papatheodoridis
Long-term outcome of chronic hepatitis C treated with interferon.
Italian journal of gastroenterology and hepatology 1999;31(6):459-61.
1999: George V Papatheodoridis; JAMES O'BEIRNE; P Mistry; Brian Davidson; Keith Rolles; Andrew Kenneth Burroughs
Mycophenolate mofetil monotherapy in stable liver transplant patients with cyclosporine-induced renal impairment: a preliminary report.
Transplantation 1999;68(1):155-7.
1999: Konstantinos Triantafyllou; Gregorios A Paspatis; A Zizi; George V Papatheodoridis; M Tzouvala; Gregorios Chlouverakis; Ioannis Elemenoglou; Dimitrios G Karamanolis
p53 protein accumulation and colonic adenoma recurrence.
European journal of gastroenterology & hepatology 1999;11(5):547-52.
1999: George V Papatheodoridis; David Patch; Anthony F Watkinson; Jonathan M Tibballs; Andrew Kenneth Burroughs
Transjugular liver biopsy in the 1990s: a 2-year audit.
Alimentary pharmacology & therapeutics 1999;13(5):603-8.
1999: George V Papatheodoridis; David Patch; Geoffrey Dusheiko; Andrew Kenneth Burroughs
The outcome of hepatitis C virus infection after liver transplantation--is it influenced by the type of immunosuppression?
Journal of hepatology 1999;30(4):731-8.
1999: George V Papatheodoridis; David Patch; G J Webster; J Brooker; E Barnes; Andrew Kenneth Burroughs
Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography.
Hepatology (Baltimore, Md.) 1999;29(4):1085-90.
1998: George V Papatheodoridis; M Hamilton; P K Mistry; B Davidson; Keith Rolles; Andrew Kenneth Burroughs
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
Gut 1998;43(5):639-44.
1998: Nicolaos C Tassopoulos; George V Papatheodoridis; Antigoni Katsoulidou; Johanna K Delladetsima; Vana Sypsa; Giota Touloumi; M Nikandros; Angelos Hatzakis
Factors associated with severity and disease progression in chronic hepatitis C.
Hepato-gastroenterology 1998;45(23):1678-83.
1998: George V Papatheodoridis; N Kapranos; M Tzouvala; Konstantinos Triantafyllou; Ioannis Elemenoglou; Dimitrios G Karamanolis
p53 and bcl-2 protein expression in rectosigmoid adenomas.
The American journal of gastroenterology 1998;93(7):1136-40.
1998: George V Papatheodoridis; M Hamilton; Keith Rolles; Andrew Kenneth Burroughs
Liver transplantation and inflammatory bowel disease.
Journal of hepatology 1998;28(6):1070-6.
1998: George V Papatheodoridis; A Zizi-Serbetzoglou; V Xourgias; Ioannis Elemenoglou; Dimitrios G Karamanolis
Indefinite dysplasia in ulcerative colitis has little clinical significance and is not associated with p53 protein accumulation.
The American journal of gastroenterology 1998;93(2):285-6.
1997: Dimitrios G Karamanolis; K C Delis; George V Papatheodoridis; E Kalafatis; Gregorios A Paspatis; V C Xourgias
Seasonal variation in exacerbations of ulcerative colitis.
Hepato-gastroenterology 1997;44(17):1334-8.
1997: George V Papatheodoridis; Johanna K Delladetsima; Antigoni Katsoulidou; Vana Sypsa; M Albrecht; G Michel; Angelos Hatzakis; Nicolaos C Tassopoulos
Significance of IgM anti-HCV core level in chronic hepatitis C.
Journal of hepatology 1997;27(1):36-41.
1997: Konstantinos Triantafyllou; George V Papatheodoridis; Gregorios A Paspatis; T H Vasilakaki; Ioannis Elemenoglou; Dimitrios G Karamanolis
Predictors of the early development of advanced metachronous colon adenomas.
Hepato-gastroenterology 1997;44(14):533-8.
1997: Nicolaos C Tassopoulos; George V Papatheodoridis; Y Kalantzakis; E Tzala; Johanna K Delladetsima; M G Koutelou; P Angelopoulou; Angelos Hatzakis
Differential diagnosis of acute HBsAg positive hepatitis using IgM anti-HBc by a rapid, fully automated microparticle enzyme immunoassay.
Journal of hepatology 1997;26(1):14-9.
1996: Dimitrios G Karamanolis; George V Papatheodoridis; V Xourgias
Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine.
European journal of gastroenterology & hepatology 1996;8(11):1083-8.
1996: George V Papatheodoridis; Konstantinos Triantafyllou; M Tzouvala; Gregorios A Paspatis; V Xourgias; Dimitrios G Karamanolis
Characteristics of rectosigmoid adenomas as predictors of synchronous advanced proximal colon neoplasms.
The American journal of gastroenterology 1996;91(9):1809-13.
1996: Nicolaos C Tassopoulos; Gerasimos Karvountzis; Giota Touloumi; Johanna K Delladetsima; George V Papatheodoridis; Antigoni Katsoulidou; G Retalis; Angelos Hatzakis
Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.
The American journal of gastroenterology 1996;91(9):1734-8.
1996: G A Lazaros; C Stavrinos; George V Papatheodoridis; Johanna K Delladetsima; A Toliopoulos; Nicolaos C Tassopoulos
Amineptine induced liver injury. Report of two cases and brief review of the literature.
Hepato-gastroenterology 1996;43(10):1015-9.
1996: G A Lazaros; George V Papatheodoridis; Johanna K Delladetsima; Nicolaos C Tassopoulos
Terbinafine-induced cholestatic liver disease.
Journal of hepatology 1996;24(6):753-6.
1996: George V Papatheodoridis; Antigoni Katsoulidou; Giota Touloumi; Johanna K Delladetsima; Angelos Hatzakis; Nicolaos C Tassopoulos
Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.
European journal of gastroenterology & hepatology 1996;8(5):469-75.
1996: Johanna K Delladetsima; George Z Rassidakis; Nicolaos C Tassopoulos; George V Papatheodoridis; T Smyrnoff; I Vafiadis
Histopathology of chronic hepatitis C in relation to epidemiological factors.
Journal of hepatology 1996;24(1):27-32.
1995: Mina Psichogiou; Nicolaos C Tassopoulos; George V Papatheodoridis; E Tzala; R Klarmann; H Witteler; George G Schlauder; H Troonen; Angelos Hatzakis
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis.
Journal of hepatology 1995;23(6):668-73.
1995: George V Papatheodoridis; Johanna K Delladetsima; S Verghisi-Nikolakaki; Melpomeni Malliori; A Krystallis; Angelos Hatzakis; Nicolaos C Tassopoulos
Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers.
The American journal of gastroenterology 1995;90(10):1843-6.
1995: George V Papatheodoridis; Johanna K Delladetsima; L Kavallierou; N Kapranos; Nicolaos C Tassopoulos
Fulminant hepatitis due to Epstein-Barr virus infection.
Journal of hepatology 1995;23(3):348-50.
1994: George V Papatheodoridis; I Delladetsima; M Koutelou; Antigoni Katsoulidou; Angelos Hatzakis; Nicolaos C Tassopoulos
Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.
Journal of hepatology 1994;20(6):843.
1994: George V Papatheodoridis; I Delladetsima; M Koutelou; Antigoni Katsoulidou; Angelos Hatzakis; Nicolaos C Tassopoulos
Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.
Journal of hepatology 1994;20(2):311.
1994: Nicolaos C Tassopoulos; Angelos Hatzakis; George V Papatheodoridis; Gerasimos Karvountzis; H Troonen; Lieselotte Lennartz
Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
Journal of hepatology 1994;20(2):305-6.
1993: Nicolaos C Tassopoulos; M G Koutelou; George V Papatheodoridis; Y S Kalantzakis; Angelos Hatzakis
Acute delta hepatitis in Greek parenteral drug abusers.
Progress in clinical and biological research 1993;382():221-7.
1993: Nicolaos C Tassopoulos; M G Koutelou; George V Papatheodoridis; H Polychronaki; I Delladetsima; T Giannikakis; A Todoulos; A Toliopoulos; Angelos Hatzakis
Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
Gut 1993;34(2 Suppl):S130-2.
1992: Nicolaos C Tassopoulos; M Koutelou; George V Papatheodoridis; H Polychronaki; T Giannikakis; M Paraloglou-Ioannides; Angelos Hatzakis
Treatment of acute non-A, non-B hepatitis with interferon alpha-2b.
Infection 1992;20(4):242.